This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Stocks to Watch: Align, Apollo

NEW YORK ( TheStreet) -- The maker of the Invisalign teeth straightening system, Align Technology (ALGN - Get Report) ended Wednesday's trading session down 3.8% to $20.37 after agreeing to acquire dentistry imaging company Cadent for $190 million.

Apollo Global Management (APO) fell 4.2% to $18.20 following rousing reception of the private-equity firm's long-awaited initial public offering Tuesday. On Wednesday, Thomson Reuters releases data highlighting mixed IPO results from Apollo's portfolio companies.
>> Apollo's IPO Gets Warm Reception

Palo Alto, Calif.-based cloud computing application maker Tibco Software (TIBX) rose 1.8% at $26.74 after edging past Wall Street's expectations for its fiscal first-quarter results. While Tibco's performance was ahead of the consensus view, the magnitude of the beat was only 5% vs. a 16% average beat in the previous eight quarters.
>> Tibco Software: After-Hours Trading

Wal-Mart (WMT - Get Report) rose 0.2% to $52.36 after a visiting positive territory as judges expressed skepticism about a large class-action lawsuit against the giant retailer over sex discrimination.

Phosphate and potash company Mosaic (MOS - Get Report) ended up 2% to $80.45 ahead of its third-quarter earnings report after the markets close Wednesday.

Chemicals company DuPont (DD - Get Report) added 1.4% to $55.37 after its subsidiary DuPont Denmark extended a $6 billion offer for food ingredients company Danisco to April 29 to allow for additional time to obtain regulatory approvals in the European Union and China. So far, shareholders representing a mere 6% stake in Danisco have accepted DuPont's offer, 90% short of the acceptances the buyer would have needed to meet its original offer closing date of April 1.

Drug company Cephalon (CEPH) is facing a hostile bid from Valeant Pharmaceuticals (VRX), which is offering $73 a share, a 24% premium to Cephalon's closing price Tuesday of $58.75.

Cephalon shares surged 28.4% to $75.44 Wednesday.

Shares of Valeant popped 12.8% to $50.08.
>> Valeant Goes Hostile With Cephalon Bid

Investment manager BlackRock (BLK - Get Report) advanced 6.6% to $198.84 as it replaces biotech company Genzyme (GENZ) in the S&P 500 after the markets close on Friday.

Discount store chain Family Dollar (FDO) fell 0.3% to $52.25 as investors took profits after the company reported second-quarter earnings of 98 cents a share. The earnings beat narrowly expectations by a penny.

>>Search for Highest Dividends by Rate or Yield
More on Earnings
Today's Top Earnings
Earnings Calendar

-- Written by Andrea Tse in New York.

>To contact the writer of this article, click here: Andrea Tse.

>To follow the writer on Twitter, go to Andrea Tse.

>To submit a news tip, send an email to:
Copyright 2010 Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ALGN $61.75 5.30%
BLK $298.82 1.50%
DD $58.86 0.27%
MOS $23.96 0.42%
WMT $66.29 0.73%


Chart of I:DJI
DOW 16,050.61 +36.23 0.23%
S&P 500 1,866.98 +14.77 0.80%
NASDAQ 4,325.4420 +56.6790 1.33%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs